Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Yiying Guo"'
Autor:
Lin Yang, Zicheng Zhang, Jiyan Dong, Yibo Zhang, Zijian Yang, Yiying Guo, Xujie Sun, Junling Li, Puyuan Xing, Jianming Ying, Meng Zhou
Publikováno v:
Pharmacological Research, Vol 194, Iss , Pp 106844- (2023)
Small-cell lung cancer (SCLC) is generally considered a 'homogenous' disease, with little documented inter-tumor heterogeneity in treatment guidance or prognosis evaluation. The precise identification of clinically relevant molecular subtypes remains
Externí odkaz:
https://doaj.org/article/8fa5b62a796a4711b2ec253464ddd2a4
Autor:
Jinyao Zhang, Xujie Sun, Li Liu, Jiyan Dong, Lei Deng, Xin Wang, Yiying Guo, Jianming Ying, Puyuan Xing, Junling Li, Lin Yang
Publikováno v:
Translational Oncology, Vol 19, Iss , Pp 101379- (2022)
Background: The roles of cancer stem cells (CSCs) and epithelial-mesenchymal transition (EMT) in solid tumors are well established. However, the interaction between CSCs and EMT in pulmonary large cell neuroendocrine carcinoma (LCNEC) remains unknown
Externí odkaz:
https://doaj.org/article/9b1d094602704150aa8fe4be32d5312c
Autor:
Yiying Guo, Lin Yang, Li Liu, Jiacong Wei, Fei Teng, Jinyao Zhang, Yixiang Zhu, Puyuan Xing, Junling Li
Publikováno v:
Thoracic Cancer, Vol 11, Iss 10, Pp 2782-2792 (2020)
Background Histologically, SCLC are classified as pure (P‐SCLC) and combined subtypes (C‐SCLC). Currently, few studies compare the clinicopathological characteristics and explore the treatment strategies applied to them. Methods Between July 2005
Externí odkaz:
https://doaj.org/article/670f682f2d884fe6bd45dea856b6c2db
Autor:
Puyuan Xing, Fan Zhang, Guoqiang Wang, Yu Xu, Chengcheng Li, Shouzheng Wang, Yiying Guo, Shangli Cai, Yan Wang, Junling Li
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-10 (2019)
Abstract Background Deciphering the correlation between immune-related adverse events (irAEs) categorized by organ system class and clinical benefit of immunotherapy is critical for clinical practice. The aim of this study is to investigate the incid
Externí odkaz:
https://doaj.org/article/d73014693b6847628e8a01bff8f7e535
Autor:
Teng Li, Xiaocong Pang, Junyun Wang, Shouzheng Wang, Yiying Guo, Ning He, Puyuan Xing, Junling Li
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundClinical evidence has shown that few non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations can benefit from immunotherapy. The tumor immune microenvironment (TIME) is a significant factor affecti
Externí odkaz:
https://doaj.org/article/7551d1f544af47a682be54002b81a28f
Autor:
Yuanliang Li, Yiying Guo, Zixuan Cheng, Chao Tian, Yingying Chen, Ruao Chen, Fuhuan Yu, Yanfen Shi, Fei Su, Shuhua Zhao, Zhizheng Wang, Jie Luo, Huangying Tan
Publikováno v:
Endocrine-Related Cancer; Sep2023, Vol. 30 Issue 9, p13-27, 15p
Autor:
Li Liu, Jiacong Wei, F. Teng, Jiyan Dong, Jianming Ying, Puyuan Xing, Yixiang Zhu, Yiying Guo, Lin Yang, Junling Li, Jinyao Zhang
Publikováno v:
Human Pathology. 108:84-92
Summary The objective of this study was to analyze the clinical and pathological characteristics of patients with small cell lung cancer (SCLC) after curative surgery and to explore prognostic factors for disease-free survival (DFS) and overall survi
Autor:
Junling Li, Jinyao Zhang, Yiying Guo, Lin Yang, Jiyan Dong, Puyuan Xing, Li Liu, Jianming Ying, Xin Wang, Jiacong Wei
Publikováno v:
Thoracic Cancer
Background Small cell lung cancer (SCLC) is one of the most aggressive lung cancers. Treatment of SCLC has remained unchanged during the past decades. Preclinical studies have revealed ASCL1 as a transcription regulator in the neuroendocrine (NE) dif
Autor:
Jinyao Zhang, Xujie Sun, Li Liu, Jiyan Dong, Lei Deng, Xin Wang, Yiying Guo, Jianming Ying, Puyuan Xing, Junling Li, Lin Yang
Publikováno v:
Translational oncology. 19
The roles of cancer stem cells (CSCs) and epithelial-mesenchymal transition (EMT) in solid tumors are well established. However, the interaction between CSCs and EMT in pulmonary large cell neuroendocrine carcinoma (LCNEC) remains unknown. The aim of
Publikováno v:
Journal of Molecular Liquids. 365:120095